SLC7A11 is under the control of many oncogenes (e.g., MiR-27a-3p, RBMS1, SOX2) in lung cancer, leading to its overactivity and ferroptosis induction resistance [[21], [22], [23]]. The gene discussed is SLC7A11; the disease is lung carcinoma.